Physician profile
Diane Smith
NPI 1508250580
$1,683.91
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $503 · 2023: $683 · 2024: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $897.29 | 2021-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.39 | 2021-2024 | Relistor |
| Boston Scientific Corporation | $140.52 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $120.95 | 2023-2024 | Senza |
| Abbvie INC. | $51.02 | 2021-2024 | |
| Ucb, INC. | $49.92 | 2023 | |
| Relievant Medsystems, INC. | $46.34 | 2021-2023 | Intracept |
| Pfizer INC. | $43.28 | 2021-2023 | |
| Allergan, INC. | $38.96 | 2021 | |
| Lilly USA, LLC | $30.03 | 2021 | |
| Almatica Pharma LLC | $30.00 | 2021 | |
| Biodelivery Sciences International, INC. | $26.89 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.37 | 2022 | |
| Amgen INC. | $15.09 | 2021 | |
| Redhill Biopharma INC. | $13.93 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $11.93 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.